Investor profile
Pymwymic has backed 15 European tech companies across 16 funding rounds between 2017 and 2026, joining rounds totalling €109M. Most active in Agritech and Foodtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Stenon | Germany | 1 | €18M |
| Resurrect Bio | UK | 2 | €16M |
| Trapview | Slovenia | 1 | €10M |
| Rival Foods | Netherlands | 1 | €10M |
| Vivent Biosignals | Switzerland |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Stenon | Series B | €18M | 2026-07 |
| Trapview | Series B | €10M | 2022-09 |
| Rival Foods | Series B | €10M | 2025-06 |
| Resurrect Bio |
| 1 |
| €7.5M |
| Doktar | Türkiye | 1 | €7.5M |
| Weenat | France | 1 | €7.4M |
| Augmenta | Greece | 1 | €6.7M |
| Fairphone | Netherlands | 1 | €6.5M |
| Kilter | Norway | 1 | €6.5M |
| BiocSol | Belgium | 1 | €4.4M |
| Seqana | Germany | 1 | €3.2M |
| Aurea Imaging | Netherlands | 1 | €2.8M |
| Onethird | Netherlands | 1 | €2.8M |
| KITRO | Switzerland | 1 | €0 |
| €8.8M |
| 2026-05 |
| Doktar | Other | €7.5M | 2025-06 |
| Vivent Biosignals | Other | €7.5M | 2025-11 |
| Weenat | Series C | €7.4M | 2024-04 |
| Resurrect Bio | Series A | €6.9M | 2026-02 |
| Augmenta | Series A | €6.7M | 2021-08 |
| Fairphone | Other | €6.5M | 2017-09 |
